These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 32805372)

  • 1. YAN, a novel microtubule inhibitor, inhibits P-gp and MRP1 function and induces mitotic slippage followed by apoptosis in multidrug-resistant A549/Taxol cells.
    Gao M; Liu T; Li J; Guan Q; Wang H; Yan S; Li Z; Zuo D; Zhang W; Wu Y
    Toxicol In Vitro; 2020 Dec; 69():104971. PubMed ID: 32805372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe.
    Bai Z; Gao M; Zhang H; Guan Q; Xu J; Li Y; Qi H; Li Z; Zuo D; Zhang W; Wu Y
    Cancer Lett; 2017 Aug; 402():81-92. PubMed ID: 28576750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-MDR efficacy of YAN against A549/Taxol cells is associated with its inhibition on glycolysis and is further enhanced by 2-deoxy-d-glucose.
    Gao M; Yang Y; Gao Y; Liu T; Guan Q; Zhou T; Shi Y; Hao M; Li Z; Zuo D; Zhang W; Wu Y
    Chem Biol Interact; 2022 Feb; 354():109843. PubMed ID: 35122754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAY, a novel tubulin inhibitor, induces cell apoptosis in A549 and A549/Taxol cells and inhibits epithelial-mesenchymal transition in A549/Taxol cells.
    Du J; Li J; Gao M; Guan Q; Liu T; Wu Y; Li Z; Zuo D; Zhang W; Wu Y
    Chem Biol Interact; 2020 May; 323():109074. PubMed ID: 32217108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
    Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
    Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CKT0353, a novel microtubule targeting agent, overcomes paclitaxel induced resistance in cancer cells.
    Dinić J; Ríos-Luci C; Karpaviciene I; Cikotiene I; Fernandes MX; Pešić M; Padrón JM
    Invest New Drugs; 2020 Jun; 38(3):584-598. PubMed ID: 31177401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-(3,4,5-trimethoxybenzoyl)-4-methyl-2-(p-tolyl) imidazol (BZML) targets tubulin and DNA to induce anticancer activity and overcome multidrug resistance in colorectal cancer cells.
    Bai Z; Liu X; Guan Q; Ding N; Wei Q; Tong B; Zhao M; Zhang W; Ma L
    Chem Biol Interact; 2020 Jan; 315():108886. PubMed ID: 31682804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell line.
    Wang NN; Zhao LJ; Wu LN; He MF; Qu JW; Zhao YB; Zhao WZ; Li JS; Wang JH
    Asian Pac J Cancer Prev; 2013; 14(9):4983-8. PubMed ID: 24175763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morin reverses P-glycoprotein-mediated multidrug-resistance in KBChR-8-5 cancer cell lines.
    Zhao Y; Xu S; Hao W; Fu Y
    Cell Biochem Funct; 2024 Jul; 42(5):e4083. PubMed ID: 38938150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol, a specific glutathione S-transferase inhibitor, overcomes the multidrug resistance (MDR)-associated protein 1-mediated MDR in small cell lung cancer.
    Filomeni G; Turella P; Dupuis ML; Forini O; Ciriolo MR; Cianfriglia M; Pezzola S; Federici G; Caccuri AM
    Mol Cancer Ther; 2008 Feb; 7(2):371-9. PubMed ID: 18281520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a lathyrane-type diterpenoid EM-E-11-4 as a novel paclitaxel resistance reversing agent with multiple mechanisms of action.
    Liu Q; Cai P; Guo S; Shi J; Sun H
    Aging (Albany NY); 2020 Feb; 12(4):3713-3729. PubMed ID: 32108588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
    Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
    Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming Taxol-resistance in A549 cells: A comprehensive strategy of targeting P-gp transporter, AKT/ERK pathways, and cytochrome P450 enzyme CYP1B1 by 4-hydroxyemodin.
    Lin H; Hu B; He X; Mao J; Wang Y; Wang J; Zhang T; Zheng J; Peng Y; Zhang F
    Biochem Pharmacol; 2020 Jan; 171():113733. PubMed ID: 31783010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells.
    Ranjbar S; Khonkarn R; Moreno A; Baubichon-Cortay H; Miri R; Khoshneviszadeh M; Saso L; Edraki N; Falson P; Firuzi O
    Toxicol Appl Pharmacol; 2019 Jan; 362():136-149. PubMed ID: 30391378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TM2, a novel semi-synthetic taxoid, exerts anti-MDR activity in NSCLC by inhibiting P-gp function and stabilizing microtubule polymerization.
    Jia L; Gao X; Fang Y; Zhang H; Wang L; Tang X; Yang J; Wu C
    Apoptosis; 2022 Dec; 27(11-12):1015-1030. PubMed ID: 36107354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming resistance to mitochondrial apoptosis by BZML-induced mitotic catastrophe is enhanced by inhibition of autophagy in A549/Taxol cells.
    Bai Z; Gao M; Xu X; Zhang H; Xu J; Guan Q; Wang Q; Du J; Li Z; Zuo D; Zhang W; Wu Y
    Cell Prolif; 2018 Aug; 51(4):e12450. PubMed ID: 29493085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Novel Triazolonaphthalimide Derivative LSS-11 Synergizes the Anti-Proliferative Effect of Paclitaxel via STAT3-Dependent MDR1 and MRP1 Downregulation in Chemoresistant Lung Cancer Cells.
    Ji L; Liu X; Zhang S; Tang S; Yang S; Li S; Qi X; Yu S; Lu L; Meng X; Liu Z
    Molecules; 2017 Oct; 22(11):. PubMed ID: 29072615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction to: YAN, a novel microtubule inhibitor, inhibits P-gp and MRP1 function and induces mitotic slippage followed by apoptosis in multidrug-resistant A549/Taxol cells.
    Gao M; Liu T; Li J; Guan Q; Wang H; Yan S; Li Z; Zuo D; Zhang W; Wu Y
    Toxicol In Vitro; 2021 Apr; 72():105033. PubMed ID: 33131967
    [No Abstract]   [Full Text] [Related]  

  • 20. Taxol Analogues Exhibit Differential Effects on Photoaffinity Labeling of β-Tubulin and the Multidrug Resistance Associated P-Glycoprotein.
    Yang CH; Wang C; Ojima I; Horwitz SB
    J Nat Prod; 2018 Mar; 81(3):600-606. PubMed ID: 29517223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.